Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 625
Selected: 0
NCT IDTitle
NCT02615223Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
NCT05235932the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT05035147Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
NCT07298538Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
NCT07729033A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for TROP2-Positive Advanced Biliary Tract Cancers Previously Treated With First-Line Immunotherapy Combined With Chemotherapy.
NCT02506361Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
NCT06863831A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
NCT02560441Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
NCT06073730Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients
NCT05854030Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma
NCT07828756Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
NCT04526028Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China
NCT05788029Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT06914037A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
NCT03671265Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
NCT06766643Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
NCT05199168Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic Esophagectomy
NCT06492447Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer
NCT03742908Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients
NCT02987244Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma
NCT02443064Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
NCT05621499HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma
NCT06404840Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
NCT04600960Eltrombopag for Chemotherapy-induced Thrombocytopenia
NCT06289751Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
NCT06375642A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
NCT07528066Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT01815853Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer
NCT07736001A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy and Safety of Trilaciclib in Preventing Myelosuppression Caused by Topoisomerase I Inhibitor Type ADC Drugs
NCT05672537Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
NCT06495515Dalpiciclib Plus Toremifene for First-line Advanced HR Positive and HER2 Negative Breast Cancer
NCT06993025Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies
NCT07263360Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
NCT07533825Laparoscopic Staging for Stage III Gastric Cancer
NCT01634984The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT07653321Acute Kidney Injury in Critically Ill Patients
NCT05678933AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT07541521RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07548060A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy
NCT02363218Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
NCT07351903A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
NCT04696432A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma
NCT06143735A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
NCT03299738A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
NCT06498154Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy
NCT07302841Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer
NCT05077839Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC
NCT04981665A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
NCT04767828A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer
NCT04273100PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC